Crossref
Bosutinib finds its place in the CML treatment paradigm
The Journal of Community and Supportive Oncology · 2013
DOI: 10.12788/j.cmonc.0002 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Community and Supportive Oncology, 2013. Verfasst von Michael Deininger.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Deininger, M. (2013). Bosutinib finds its place in the CML treatment paradigm. The Journal of Community and Supportive Oncology. https://doi.org/10.12788/j.cmonc.0002
Vancouver
Deininger M. Bosutinib finds its place in the CML treatment paradigm. The Journal of Community and Supportive Oncology. 2013. doi:10.12788/j.cmonc.0002
BibTeX
@article{Deininger2013,
author = {Deininger, Michael},
title = {Bosutinib finds its place in the CML treatment paradigm},
journal = {The Journal of Community and Supportive Oncology},
year = {2013},
doi = {10.12788/j.cmonc.0002}
}
EUVIMED